These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3909342)

  • 41. Cefotaxime therapy of serious infections with multiresistant gram-negative bacilli.
    Clumeck N; van Laethem Y; Vanhoof R; George C; Rapin M; Butzler JP
    Scand J Infect Dis; 1982; 14(1):57-60. PubMed ID: 6280269
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful response of severe neonatal gram-negative infection to treatment with aztreonam.
    Constantopoulos A; Thomaidou L; Loupa H; Papoulias G
    Chemotherapy; 1989; 35 Suppl 1():101-5. PubMed ID: 2731446
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aztreonam: early clinical studies in New Jersey.
    Johnson ES; Eng RK; Perez EM; Smith LG
    N J Med; 1986 Jan; Spec No():26-9. PubMed ID: 3513061
    [No Abstract]   [Full Text] [Related]  

  • 44. Aztreonam plus clindamycin vs. tobramycin plus clindamycin for the treatment of intraabdominal infections.
    Birolini D; Moraes MF; de Souza OS
    Rev Infect Dis; 1985; 7 Suppl 4():S724-8. PubMed ID: 3909330
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aztreonam in the treatment of urinary tract infections: a multicenter trial.
    Martelli A; Cortecchia V; Ventriglia L
    Chemotherapy; 1989; 35 Suppl 1():8-14. PubMed ID: 2659294
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Review of the clinical pharmacology of the monobactam antibiotic aztreonam.
    Swabb EA
    Am J Med; 1985 Feb; 78(2A):11-8. PubMed ID: 3881946
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [An Italian multicenter study on the efficacy and tolerability of aztreonam in the treatment of urinary tract infections].
    Martelli A; Cortecchia V; Ventriglia L
    Clin Ter; 1988 May; 125(3):191-201. PubMed ID: 2973940
    [No Abstract]   [Full Text] [Related]  

  • 48. Safety profile of aztreonam in clinical trials.
    Newman TJ; Dreslinski GR; Tadros SS
    Rev Infect Dis; 1985; 7 Suppl 4():S648-55. PubMed ID: 2934785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of gram-negative infections with aztreonam.
    Simons WJ; Lee TJ
    Am J Med; 1985 Feb; 78(2A):27-30. PubMed ID: 4038577
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics and extravascular penetration of aztreonam in patients with abdominal sepsis.
    Winslade NE; Smith IL; Simons GW; Swanson DJ; Vigano A; Wels PB; Schentag JJ
    Rev Infect Dis; 1985; 7 Suppl 4():S716-23. PubMed ID: 3909329
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Randomized comparison of aztreonam and cefuroxime in gram-negative upper urinary tract infections.
    Friman G; Cars O; Bäck E; Beckman H; Carlsson M; Forssell J; Fredlund H; Neringer R; Odenholt-Tornqvist I; Rydén C
    Infection; 1989; 17(5):284-9. PubMed ID: 2689345
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
    Scully BE; Neu HC
    Am J Med; 1985 Feb; 78(2):251-61. PubMed ID: 4038574
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aztreonam.
    Clark P
    Obstet Gynecol Clin North Am; 1992 Sep; 19(3):519-28. PubMed ID: 1436929
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of aztreonam in lower respiratory tract infections.
    Cook JL
    Urology; 1988 Jun; 31(6 Suppl):33-6. PubMed ID: 3287748
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aztreonam, a new monobactam antimicrobial.
    Guay DR; Koskoletos C
    Clin Pharm; 1985; 4(5):516-26. PubMed ID: 3902330
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of aztreonam in treatment of complicated urinary tract infections in children.
    Kline MW
    Pediatr Infect Dis J; 1989 Sep; 8(9 Suppl):S113-6; discussion S128-32. PubMed ID: 2682509
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Aztreonam as monotherapy in urinary tract infections with a systemic repercussion in patients with a relative contraindication for the use of aminoglycosides].
    Pedrajas JM; Pieltain R; Mesa N; Ramón P; García C; Pontes JC; Fernández-Cruz A
    Rev Clin Esp; 1993 Apr; 192(6):256-9. PubMed ID: 8497718
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aztreonam compared with gentamicin for treatment of serious urinary tract infections.
    Sattler FR; Moyer JE; Schramm M; Lombard JS; Appelbaum PC
    Lancet; 1984 Jun; 1(8390):1315-8. PubMed ID: 6145024
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aztreonam in the treatment of urinary tract infection.
    Childs SJ
    Am J Med; 1985 Feb; 78(2A):44-6. PubMed ID: 3881948
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Efficiency and possibility of the use of aztreonam in bacterial infections caused by gram-negative organisms].
    Caramia G; Compagnoni L; Pettinari A; Gregorini S
    Minerva Pediatr; 1986 Sep; 38(17-18):773-7. PubMed ID: 3796535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.